Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction.

Autor: Sun L; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China., Hu Y; Department of Cardiology, The First Affiliated Hospital of Henan University of CM, Zhengzhou City, Henan Province, China., Mishra A; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India., Sreeharsha N; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia., Moktan JB; Department of Pharmacy Practice, Sri Adichunchanagiri College of Pharmacy, BG Nagara, Mandya, Karnataka, India., Kumar P; Shikhar Institute of Pharmacy, Shekhupur, Budaun, Uttar Pradesh, India., Wang L; Department of Cardiology, Jinan Central Hospital Affiliated to Shandong University, Jinan City, Shandong Province, China.
Jazyk: angličtina
Zdroj: BioFactors (Oxford, England) [Biofactors] 2020 May; Vol. 46 (3), pp. 421-431. Date of Electronic Publication: 2020 Jan 11.
DOI: 10.1002/biof.1611
Abstrakt: Our study is aimed at evaluating the effects of pretreatment with Poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol (RSV PLGA NPs) compared to conventional resveratrol (RSV) on isoproterenol (ISO) induced myocardial infarction (MI) in rats. Sixty rats were randomly divided into six groups of 10 rats each. RSV and RSV PLGA NPs were given by gavage in two different doses (50 mg/kg body weight [BW] and 100 mg/kg BW) for 3 weeks. RSV and RSV PLGA NPs were given for 2 weeks starting 1 week before ISO administration. The blood samples were taken 24 hr after the last dose of ISO. The antioxidant, anti-inflammatory, and cardioprotective effects were evaluated in all groups. Only 100 mg/kg dose of RSV and both doses of RSV PLGA NPs offered a cardioprotective effect by preventing cardiac troponin T (cTnT) levels, lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) activities leakage from cardiomyocytes, with the best result for RSV PLGA NPs. All the oxidative stress parameters were significantly improved after RSV PLGA NPs compared to RSV pretreatment. RSV PLGA NPs were more efficient than RSV in limiting the increase in inflammatory cytokine expressions such as tumor necrosis factor-alpha (TNF-α), interleukin 1 beta (IL-1β), and NF-kappaB (NF-kB) expression. In addition, RSV PLGA NPs significantly upregulated eNOS expression and downregulated iNOS expression. RSV PLGA NPs better prevented myocardial necrosis and reduced interstitial edema and neutrophil infiltration than RSV, on histopathological examination. Therefore, improving the bioactivity of RSV by nanotechnology may help limit cardiac injury after myocardial infarction.
(© 2020 International Union of Biochemistry and Molecular Biology.)
Databáze: MEDLINE